These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1903226)
1. [Activation of the Ha-ras oncogene in tumors induced in mice by transplacental exposure to 7,12-dimethylbenz(a)anthracene]. Loktionov AS; Hollstein M; Martel N; Galendo D; Tomatis L; Yamasaki H Vopr Onkol; 1991; 37(3):297-303. PubMed ID: 1903226 [TBL] [Abstract][Full Text] [Related]
2. [Mutations in the 61st codon of the c-Ki-ras oncogene during transplacental lung tumor induction in mice and their difference in spontaneous and induced tumors]. Loktionov AS Mol Biol (Mosk); 1991; 25(6):1517-25. PubMed ID: 1813798 [TBL] [Abstract][Full Text] [Related]
3. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice. Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892 [TBL] [Abstract][Full Text] [Related]
4. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras. Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761 [TBL] [Abstract][Full Text] [Related]
5. Tissue-specific activating mutations of Ha- and Ki-ras oncogenes in skin, lung, and liver tumors induced in mice following transplacental exposure to DMBA. Loktionov A; Hollstein M; Martel N; Galendo D; Cabral JR; Tomatis L; Yamasaki H Mol Carcinog; 1990; 3(3):134-40. PubMed ID: 1973614 [TBL] [Abstract][Full Text] [Related]
6. Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidine. Zhang Z; Diwan BA; Anderson LM; Logsdon D; Olivero OA; Haines DC; Rice JM; Yuspa SH; Poirier MC Mol Carcinog; 1998 Sep; 23(1):45-51. PubMed ID: 9766437 [TBL] [Abstract][Full Text] [Related]
7. Role of oncogene activation during prenatal (transplacental) initiation and postnatal promotion of mouse skin tumours. Yamasaki H; Hollstein M; Cabral JR; Tomatis L IARC Sci Publ; 1989; (96):221-37. PubMed ID: 2680947 [TBL] [Abstract][Full Text] [Related]
8. Transplacental and transgeneration carcinogenic effect of 7,12-dimethylbenz[a]anthracene: relationship with ras oncogene activation. Loktionov A; Popovich I; Zabezhinski M; Martel N; Yamasaki H; Tomatis L Carcinogenesis; 1992 Jan; 13(1):19-24. PubMed ID: 1733568 [TBL] [Abstract][Full Text] [Related]
9. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis. Buchmann A; Karcier Z; Schmid B; Strathmann J; Schwarz M Mutat Res; 2008 Feb; 638(1-2):66-74. PubMed ID: 17928010 [TBL] [Abstract][Full Text] [Related]
10. [Presence of specific mutation of Ha-ras oncogene in skin tumors of mice induced under different experimental conditions]. Loktionov AS; Popovich IG; Zabezhinskiĭ MA; Anisimov VN Biull Eksp Biol Med; 1991 Apr; 111(4):398-400. PubMed ID: 1909909 [TBL] [Abstract][Full Text] [Related]
11. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415 [TBL] [Abstract][Full Text] [Related]
12. Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells. Sasaki K; Bertrand O; Nakazawa H; Fitzgerald DJ; Mironov N; Yamasaki H Cancer Res; 1995 Aug; 55(16):3513-6. PubMed ID: 7627957 [TBL] [Abstract][Full Text] [Related]
13. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene. Goodrow T; Reynolds S; Maronpot R; Anderson M Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119 [TBL] [Abstract][Full Text] [Related]
14. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice. Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158 [TBL] [Abstract][Full Text] [Related]
15. c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis. Kwong YY; Husain Z; Biswas DK Oncogene; 1992 Aug; 7(8):1481-9. PubMed ID: 1630811 [TBL] [Abstract][Full Text] [Related]
16. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model. Corominas M; Leon J; Kamino H; Cruz-Alvarez M; Novick SC; Pellicer A Oncogene; 1991 Apr; 6(4):645-51. PubMed ID: 1840681 [TBL] [Abstract][Full Text] [Related]
17. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice. Wang Y; Wang Y; Stoner G; You M Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632 [TBL] [Abstract][Full Text] [Related]
18. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584 [TBL] [Abstract][Full Text] [Related]
19. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. Owens DM; Spalding JW; Tennant RW; Smart RC Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738 [TBL] [Abstract][Full Text] [Related]
20. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways. Jhappan C; Takayama H; Dickson RB; Merlino G Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]